Clinical Trial

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Terminated Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
Sponsor decision
Summary
A phase 1 study of 68Ga-R11228 and 177Lu-R11228 in breast cancer.
Protocol Amendment History 5 changes
critical Trial terminated 2026-07-14
critical Reason stopped changed: — → Sponsor decision 2026-07-14
notable Enrollment reduced: 62 -> 11 participants 2026-07-14
notable Primary completion moved earlier: 2028-06-01 -> 2026-06-01 2026-07-14
minor Completion moved earlier: 2033-06-01 -> 2026-06-30 2026-07-14
Trial Details
NCT Number NCT07121244
Lead Sponsor Radionetics Oncology
Conditions Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer
Enrollment 11 participants
Start Date 2025-10-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-13